Florentina Negoita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Florentina Negoita has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Karin G. Stenkula
Department of Experimental Medical Science, Lund University, Sweden
3 shared publications - Conchita Fraguas Bringas
University of Copenhagen
2 shared publications - Johanna Säll
Department of Experimental Medical Science, Lund University, Lund, Sweden
2 shared publications - Kei Sakamoto
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
2 shared publications Kristina Hellberg
University of Copenhagen
2 shared publications- Olga Göransson
Department of Experimental Medical Science, Lund University, Lund, Sweden
2 shared publications
Latest Publications
- Open Access
- 23 February 2026
- Published by Taylor & Francis in Autophagy
- Vol. 22 (6) , 1386-1400
AMPK promotes TFEB transcriptional activity through dephosphorylation at both MTORC1-dependent and -independent sites
TFEB (transcription factor EB) and related TFE3 (transcription factor binding to IGHM enhancer 3) are members of the basic helix-loop-helix leucine zipper family of transcription factors [1]. TFEB ...
- 23 February 2026
- Published by Taylor & Francis in Autophagy
- Vol. 22 (6) , 1386-1400
Open AccessAMPK promotes TFEB transcriptional activity through dephosphorylation at both MTORC1-dependent and -independent sites
TFEB (transcription factor EB) and related TFE3 (transcription factor binding to IGHM enhancer 3) are members of the basic helix-loop-helix leucine zipper family of transcription factors [1]. TFEB ...
- Open Access
AMPK activation promotes transcriptional activation of TFEB through its dephosphorylation
Transcription Factor EB (TFEB) is a critical regulator of lysosomal biogenesis, autophagy and energy homeostasis through controlling expression of genes belonging to the coordinated lysosomal expression and regulation network. AMP-activated protein kinase (AMPK) has been reported to phosphorylate TFEB at three conserved C-terminal serine residues (S466, S467, S469) and these phosphorylation events were essential for transcriptional activation of TFEB. In sharp contrast to this proposition, here we demonstrate that AMPK activation leads to dephosphorylation of the C-terminal sites, and that AMPK is dispensable for mTORC1-mediated/torin1-sensitive TFEB activation. We show that a synthetic peptide encompassing C-terminal serine residues of TFEB is a poor substrate of AMPK. Treatment of cells with AMPK activator (MK-8722) or mTOR inhibitor (torin1) robustly dephosphorylated TFEB not only at mTORC1-targeted N-terminal serine sites, but also at the C-terminal sites. Loss of function of AMPK abrogated MK-8722-but not torin1-induced dephosphorylation and induction of the vast majority of TFEB target genes.
Open AccessAMPK activation promotes transcriptional activation of TFEB through its dephosphorylation
Transcription Factor EB (TFEB) is a critical regulator of lysosomal biogenesis, autophagy and energy homeostasis through controlling expression of genes belonging to the coordinated lysosomal expression and regulation network. AMP-activated protein kinase (AMPK) has been reported to phosphorylate TFEB at three conserved C-terminal serine residues (S466, S467, S469) and these phosphorylation events were essential for transcriptional activation of TFEB. In sharp contrast to this proposition, here we demonstrate that AMPK activation leads to dephosphorylation of the C-terminal sites, and that AMPK is dispensable for mTORC1-mediated/torin1-sensitive TFEB activation. We show that a synthetic peptide encompassing C-terminal serine residues of TFEB is a poor substrate of AMPK. Treatment of cells with AMPK activator (MK-8722) or mTOR inhibitor (torin1) robustly dephosphorylated TFEB not only at mTORC1-targeted N-terminal serine sites, but also at the C-terminal sites. Loss of function of AMPK abrogated MK-8722-but not torin1-induced dephosphorylation and induction of the vast majority of TFEB target genes.
- 1 March 2019
- Published by Elsevier in Cellular Signalling
- Vol. 55, 73-80
Insulin induces Thr484 phosphorylation and stabilization of SIK2 in adipocytes
- 1 March 2019
- Published by Elsevier in Cellular Signalling
- Vol. 55, 73-80
Insulin induces Thr484 phosphorylation and stabilization of SIK2 in adipocytes
- 1 January 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 508 (3) , 775-779
Salt-inducible kinase 2 regulates TFEB and is required for autophagic flux in adipocytes
- 1 January 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 508 (3) , 775-779
Salt-inducible kinase 2 regulates TFEB and is required for autophagic flux in adipocytes
- 1 September 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (1) , 343-356
PNPLA3 variant M148 causes resistance to starvation‐mediated lipid droplet autophagy in human hepatocytes
The mechanism of how patatin‐like phospholipase domain‐containing protein 3 (PNPLA3) variant M148 is associated with increased risk of development of hepatic steatosis is still debated. Here, we propose a novel role of PNPLA3 as a key player during autophagosome formation in the process of lipophagy. A human hepatocyte cell line, HepG2 cells, expressing recombinant I148 or 148M, was used to study lipophagy under energy deprived conditions, and lipid droplet morphology was investigated using florescence microscopy, image analysis and biochemical assays. Autophagic flux was studied using the golden‐standard of LC3‐II turnover in combination with the well characterized GFP‐RFP‐LC3 vector. To discriminate between, perturbed autophagic initiation and lysosome functionality, lysosomes were characterized by Lysotracker staining and LAMP1 protein levels as well as activity and activation of cathepsin B. For validation, human liver biopsies genotyped for I148 and 148M were analyzed for the presence of LC3‐II and PNPLA3 on lipid droplets. We show that the M148‐PNPLA3 variant is associated with lipid droplets that are resistant to starvation‐mediated degradation. M148 expressing hepatocytes reveal decreased autophagic flux and reduced lipophagy. Both I148‐PNPLA3 and M148‐PNPLA3 colocalize and interact with LC3‐II, but the M148‐PNPLA3 variant has lower ability to bind LC3‐II. Together, our data indicate that PNPLA3 might play an essential role in lipophagy in hepatocytes and furthermore that the M148‐PNPLA3 variant appears to display a loss in this activity, leading to decreased lipophagy.
- 1 September 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (1) , 343-356
PNPLA3 variant M148 causes resistance to starvation‐mediated lipid droplet autophagy in human hepatocytes
The mechanism of how patatin‐like phospholipase domain‐containing protein 3 (PNPLA3) variant M148 is associated with increased risk of development of hepatic steatosis is still debated. Here, we propose a novel role of PNPLA3 as a key player during autophagosome formation in the process of lipophagy. A human hepatocyte cell line, HepG2 cells, expressing recombinant I148 or 148M, was used to study lipophagy under energy deprived conditions, and lipid droplet morphology was investigated using florescence microscopy, image analysis and biochemical assays. Autophagic flux was studied using the golden‐standard of LC3‐II turnover in combination with the well characterized GFP‐RFP‐LC3 vector. To discriminate between, perturbed autophagic initiation and lysosome functionality, lysosomes were characterized by Lysotracker staining and LAMP1 protein levels as well as activity and activation of cathepsin B. For validation, human liver biopsies genotyped for I148 and 148M were analyzed for the presence of LC3‐II and PNPLA3 on lipid droplets. We show that the M148‐PNPLA3 variant is associated with lipid droplets that are resistant to starvation‐mediated degradation. M148 expressing hepatocytes reveal decreased autophagic flux and reduced lipophagy. Both I148‐PNPLA3 and M148‐PNPLA3 colocalize and interact with LC3‐II, but the M148‐PNPLA3 variant has lower ability to bind LC3‐II. Together, our data indicate that PNPLA3 might play an essential role in lipophagy in hepatocytes and furthermore that the M148‐PNPLA3 variant appears to display a loss in this activity, leading to decreased lipophagy.